Publications by authors named "Jixia Ren"

Claim this Profile
S
Substrate promiscuity catalyzed by an -glycosyltransferase MrOGT2 from .
Yihan Ma, Jixia Ren, Wen-Bing Yin, Xiaoqing Liu, Wei Li

Mycology· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of low-toxicity DNA topoisomerase I inhibitors with potential blood-brain barrier penetrability for glioblastoma therapy: structure-based virtual screening reveals promising novel Scaffolds.
Ya-Lin Li, Jun Mao, Zhong Cheng, Xin-Yu Zhou, Duan-Na Zhang, Ji-Xia Ren

Mol Divers· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polyphyllin I induces rapid ferroptosis in acute myeloid leukemia through simultaneous targeting PI3K/SREBP-1/SCD1 axis and triggering of lipid peroxidation.
Xinyu Zhou, Duanna Zhang, Jieting Lei, Jixia Ren, Bo Yang

J Nat Med· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying Novel ATX Inhibitors via Combinatory Virtual Screening Using Crystallography-Derived Pharmacophore Modelling, Docking Study, and QSAR Analysis.
Ji-Xia Ren, Rui-Tao Zhang, Hui Zhang

Molecules· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of an in silico prediction model for chemical-induced urinary tract toxicity by using naïve Bayes classifier.
Hui Zhang, Ji-Xia Ren, Jin-Xiang Ma, Lan Ding

Mol Divers· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of novel DHFR inhibitors for treatment of tuberculosis by combining virtual screening with in vitro activity assay.
Nan Wang, Ji-Xia Ren, Yong Xie

J Biomol Struct Dyn· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and evaluation of in silico prediction model for drug-induced respiratory toxicity by using naïve Bayes classifier method.
Hui Zhang, Jin-Xiang Ma, Chun-Tao Liu, Ji-Xia Ren, Lan Ding

Food Chem Toxicol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In silico approaches to identify novel myeloid cell leukemia-1 (Mcl-1) inhibitors for treatment of cancer.
Ji-Xia Ren, Cheng-Ping Li, Xiu-Ling Zhou, Xue-Song Cao, Yong Xie

J Biomol Struct Dyn· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of novel prediction model for drug-induced mitochondrial toxicity by using naïve Bayes classifier method.
Hui Zhang, Peng Yu, Ji-Xia Ren, Xi-Bo Li, He-Li Wang

Food Chem Toxicol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Crystal structure of the second fibronectin type III (FN3) domain from human collagen α1 type XX.
Jingfeng Zhao, Jixia Ren, Nan Wang, Zhong Cheng, Runmei Yang

Acta Crystallogr F Struct Biol Commun· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of novel in silico model for developmental toxicity assessment by using naïve Bayes classifier method.
Hui Zhang, Ji-Xia Ren, Yan-Li Kang, Peng Bo, Jun-Yu Liang

Reprod Toxicol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of novel dual-specificity phosphatase 26 inhibitors by a hybrid virtual screening approach based on pharmacophore and molecular docking.
Ji-Xia Ren, Zhong Cheng, Yu-Xin Huang, Jing-Feng Zhao, Peng Guo

Biomed Pharmacother· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of novel VP35 inhibitors: Virtual screening driven new scaffolds.
Ji-Xia Ren, Rui-Tao Zhang, Hui Zhang, Xue-Song Cao, Li-Ke Liu

Biomed Pharmacother· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Homology modeling and virtual screening for inhibitors of lipid kinase PI(4)K from Plasmodium.
Ji-Xia Ren, Na-Na Gao, Xue-Song Cao, Quan-An Hu, Yong Xie

Biomed Pharmacother· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of novel potent human testis-specific and bromodomain-containing protein (BRDT) inhibitors using crystal structure-based virtual screening.
Nana Gao, Jixia Ren, Li Hou, Yue Zhou, Ling Xin

Int J Mol Med· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virtual screening for the identification of novel inhibitors of Mycobacterium tuberculosis cell wall synthesis: inhibitors targeting RmlB and RmlC.
Ji-Xia Ren, Huo-Lian Qian, Yu-Xin Huang, Ning-Yu Zhu, Shu-Yi Si

Comput Biol Med· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression, purification and preliminary crystallographic studies of the C-terminal SH3 domain of human Tks4.
Yuxin Huang, Huolian Qian, Xiaoying Wang, Zhong Cheng, Jixia Ren

Acta Crystallogr F Struct Biol Commun· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacophore modeling and hybrid virtual screening for the discovery of novel IκB kinase 2 (IKK2) inhibitors.
Huan-Zhang Xie, Ling-Yun Liu, Ji-Xia Ren, Jian-Ping Zhou, Ren-Lin Zheng

J Biomol Struct Dyn· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of novel Pim-1 kinase inhibitors by a hierarchical multistage virtual screening approach based on SVM model, pharmacophore, and molecular docking.
Ji-Xia Ren, Lin-Li Li, Ren-Lin Zheng, Huan-Zhang Xie, Zhi-Xing Cao

J Chem Inf Model· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacophore modeling and virtual screening for the discovery of new transforming growth factor-beta type I receptor (ALK5) inhibitors.
Ji-Xia Ren, Lin-Li Li, Jun Zou, Li Yang, Jin-Liang Yang

Eur J Med Chem· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacophore modeling study based on known spleen tyrosine kinase inhibitors together with virtual screening for identifying novel inhibitors.
Huan-Zhang Xie, Lin-Li Li, Ji-Xia Ren, Jun Zou, Li Yang

Bioorg Med Chem Lett· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacophore modeling studies of type I and type II kinase inhibitors of Tie2.
Qing-Qing Xie, Huan-Zhang Xie, Ji-Xia Ren, Lin-Li Li, Sheng-Yong Yang

J Mol Graph Model· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Towards more accurate pharmacophore modeling: Multicomplex-based comprehensive pharmacophore map and most-frequent-feature pharmacophore model of CDK2.
Jun Zou, Huan-Zhang Xie, Sheng-Yong Yang, Jin-Juan Chen, Ji-Xia Ren

J Mol Graph Model· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis